DEDN6526A
DEDN6526A is an antibody-drug conjugate (ADC) consisting of the humanized anti-ETBR antibody DEDN6526A (RG-7636) and the tubulin inhibitor MMAE (McMMAF) (HY-15575). DEDN6526A induces apoptosis and can be used in melanoma research[1].
Product Specifications
UNSPSC
12352203
Target
Antibody-Drug Conjugates (ADCs) ; Apoptosis; Endothelin Receptor; Microtubule/Tubulin
Related Pathways
Antibody-drug Conjugate/ADC Related; Apoptosis; Cell Cycle/DNA Damage; Cytoskeleton; GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[DEDN6526A]
References & Citations
[1]Sandhu S, et al. Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma. Invest New Drugs. 2020 Jun;38 (3) :844-854.
Shipping Conditions
Room temperature
Scientific Category
ADC Related
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740676-100 1x 100 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880892-500 1x 500 µL
MiTF (Microphthalmia Transcription Factor) (C5/D5), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 